XW043FBIntroduction of Valoctocogene Roxaparvovec-rvox into Central Vein, Percutaneous Approach, New Technology Group 11

New Technology›Anatomical Regions›Introduction
ICD-10-PCS XW043FB
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

XW043FB is a billable ICD-10-PCS procedure code for Introduction of Valoctocogene Roxaparvovec-rvox into Central Vein, Percutaneous Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Code Identity

ICD-10-PCS Code
XW043FB
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Valoctocogene Roxaparvovec-rvox into Central Vein, Percutaneous Approach, New Technology Group 11
Parent Code
XW0
Short Description
Introduce Valoct Roxaparv in Central Vein, Perc, New Tech 1

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPart4Central Vein
5Approach3Percutaneous
6Device/Substance/TechnologyFValoctocogene Roxaparvovec-rvox
7QualifierBNew Technology Group 11

Code History

FY 2026New code, effective October 1, 2025.
Replaces previously assigned code(s):
  • 3E043GC — Introduce Oth Therap Subst in Central Vein, Perc

Similar Procedure Codes

Questions About XW043FB

Is XW043FB a billable code?

Yes. XW043FB is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Valoctocogene Roxaparvovec-rvox into Central Vein, Percutaneous Approach, New Technology Group 11 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XW043FB mean?

XW043FB breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 4 is the BodyPart (Central Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character F is the Device/Substance/Technology (Valoctocogene Roxaparvovec-rvox); the 7th character B is the Qualifier (New Technology Group 11).